| View |
|
DRP-15033
|
Bupivacaine hydrochloride
|
Recaine
|
5 mg/mL (0.5% w/v)
|
Solution for Intrathecal Injection
|
Local Anesthetic (Amide).
|
Reyon Pharmaceuticals Co., Ltd.
|
Korea
|
Initial
|
20 March 2024
|
20 March 2029
|
| View |
|
DRP-15028
|
Multivitamins + Minerals
|
Xanoca Performs
|
Formulation:
Each effervescent tablet contains: Ascorbic Acid 500 mg
Pantothenic Acid (Vitamin B5) (as Calcium Pantothenate) 23 mg Niacinamide (Vitamin B3) 50 mg
Thiamine Hydrochloride (Vitamin B1) 15 mg Riboflavin (Vitamin B2)
(as Riboflavin Sodium Phosphate) 15 mg Pyridoxine Hydrochloride (Vitamin B6) 10 mg
Cyanocobalamin (Vitamin B12) 10 mcg Calcium (as Calcium Carbonate) 100 mg Magnesium (as Magnesium Sulphate anhydrous, Magnesium Carbonate) 100 mg Zinc (as Zinc Monohydrate) 10 mg
Folic Acid 400 mcg
Biotin 150 mcg
|
Effervescent
Tablet (Berry Flavor)
|
Vitamin/Mineral
|
Vovantis Laboratories Private Limited
|
India
|
Initial [OTC]
|
19 March 2024
|
19 March 2029
|
| View |
|
DRP-14965
|
Paracetamol + Phenylphrine HCI + Chlorpheniramine
Maleate
|
Coldmedic Night
|
500 mg/10 mg/4 mg
|
Tablet
|
Antipyretic/Analgesic/Antihistamine/
Nasal Decongestant
|
Medley Pharmaceuticals Limited
|
India
|
Initial [OTC]
|
19 May 2024
|
19 May 2029
|
| View |
|
DR-XY49023
|
Retinol Palmitate (Vitamin A)
|
None
|
100,000 IU
|
Softgel Capsule
|
Vitamins
|
Northfield Laboratories Inc.
|
Philippines
|
Initial
|
21 March 2024
|
21 March 2029
|
| View |
|
DRP-15034
|
Teicoplanin
|
Teiconova-400
|
400 mg
|
Powder for Solution for Injection (IM/IV)
|
Antibacterial (Glycopeptide antibacterial)
|
Dongkook Pharmaceutical Co., Ltd.
|
Korea
|
Initial
|
21 March 2024
|
21 March 2029
|
| View |
|
DRP-15030
|
Co-Amoxiclav
|
Ricoxin
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Baroque Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
24 September 2024
|
21 March 2029
|
| View |
|
DRP-15029
|
Adenosine
|
Adenox
|
3 mg/mL (6 mg/2 mL)
|
Solution for I.V. Injection
|
Antiarrhythmic Agent
|
Farbe Firma Pvt. Ltd.
|
India
|
Initial
|
21 March 2024
|
21 March 2029
|
| View |
|
DRP-15035
|
Tranexamic acid
|
Tracid
|
100 mg/mL (500 mg/5 mL)
|
Solution for Injection (IV)
|
Antifibrinolytic
|
Swiss Parenterals Ltd. (Block-B)
|
India
|
Initial
|
22 March 2024
|
22 March 2029
|
| View |
|
DR-XY49024
|
Topotecan (as hydrochloride)
|
Toponova
|
4mg
|
Powder for Concentrate Solution for Infusion
|
Antineoplastic Agent [Topoisomerase 1 (TOP1)
Inhibitor]
|
Venus Remedies, Limited.
|
India
|
Initial
|
22 March 2024
|
22 March 2029
|
| View |
|
DRHR-2352
|
Ethyl Alcohol
|
Perfect Defense
|
70 mg/100 mg (70% v/v)
|
Solution (Mellow Green
Scent)
|
Antiseptic/Disinfectant
|
Zelwalk Enterprises
|
Philippines
|
Initial
|
22 March 2024
|
22 March 2029
|
| View |
|
DRP-5973-05
|
Docetaxel (as trihydrate)
|
Doxetacent
|
80 mg / 2 mL
|
Concentrate Solution for I.V. Infusion
|
Antineoplastic (Taxane)
|
Getwell Pharmaceuticals
|
India
|
Renewal
|
28 April 2024
|
28 January 2030
|
| View |
|
DRP-11724-01
|
Ciprofloxacin (as Hydrochloride)
|
Cirok
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolone)
|
Ratnatris Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
05 May 2023
|
25 April 2027
|
| View |
|
DRP-10710-03
|
Piperacillin (As Sodium) + Tazobactam (As Sodium)
|
Rytam
|
4g/500mg
|
Powder for Injection (IV)
|
Antibacterial (Penicillin/Beta-lactamase inhibitor)
|
Reyoung Pharmaceutical Co. Ltd
|
China
|
CLIDP Conversion
|
07 April 2023
|
01 December 2026
|
| View |
|
BRP-039-01
|
Heparin Sodium
|
Hemolate
|
5000 IU/ mL (25000 IU/mL)
|
Solution for Injection (IV/SC)
|
Anticoagulant
|
Troikaa Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
10 March 2024
|
02 January 2027
|
| View |
|
BRP-090-01
|
Equine Anti-rabies Immunoglobulin
|
Zenuine
|
200 IU/mL (1,000 IU/5 mL)
|
Solution for Injection (IM)
|
Immunoglobulins
|
Vins Bioproducts, Ltd.
|
India
|
Renewal
|
05 April 2024
|
16 March 2029
|
| View |
|
DR-XY437888
|
Valsartan
|
Valvex 80
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
WEST-COAST PHARMACEUTICAL WORKS LTD
|
India
|
Renewal
|
12 March 2024
|
09 October 2029
|
| View |
|
DRHR-1969
|
Ethyl Alcohol
|
Casino – Active
|
70% (v/v)
|
Solution
|
Antiseptic / Disinfectant
|
International Pharmaceuticals, Inc.
|
Philippines
|
Renewal
|
25 March 2024
|
22 July 2029
|
| View |
|
DRP-10076-01
|
Lansoprazole
|
Lansoquest
|
30 mg
|
Delayed Release Capsule
|
Proton Pump Inhibitor
|
Friends Pharma (Pvt.) Ltd
|
Pakistan
|
Renewal
|
24 March 2024
|
28 April 2026
|
| View |
|
DRP-10455-01
|
Paracetamol + Thiamine Hydrochloride (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
None
|
500 mg / 50 mg / 100 mg / 100 mcg /
|
Film-Coated Tablet
|
Analgesic/ Antipyretic/ Vitamins
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
Renewal
|
26 March 2024
|
01 October 2026
|
| View |
|
DRP-10525-02
|
Cefoperazone (as sodium) + Sulbactam (as sodium)
|
Winpersul
|
1 g / 500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
13 March 2024
|
11 October 2026
|